Johnson & Johnson

Investor type

CVC

Founded

-

AUM

-

Location

United States

Investment Ticket

$0-1 m

Investment Stage

Seed Series B

Region of investment

North America Europe

ESG Focus

Impact investor
Investor profile last updated: 27 November, 2021

Profile

Johnson & Johnson Innovation – JJDC, Inc. (JJDC) is the strategic venture capital arm of Johnson & Johnson. JJDC pursues opportunities to solve critical healthcare needs. Our portfolio companies benefit from the full global capabilities of Johnson & Johnson as we collaborate to drive innovation.

JJDC finds transformative ideas and helps them mature into real solutions for today’s patients.

Guided by a clear, consistent investment strategy aligned with scientific goals, JJDC works hand-in-hand with partners to navigate the path to creating breakthrough health innovations.

We invest across sectors—pharmaceuticals, medical devices and consumer healthcare—and at all stages, from seed-level startups to Series B and beyond.

All of our portfolio companies receive the same unwavering commitment. We take a long-term approach, deploying the full capabilities of the Johnson & Johnson family of companies, including discovery, clinical development, regulatory affairs, manufacturing and commercialization.

Our team includes leaders in the healthcare and technology communities, many with deep R&D experience. This gives us the ability to understand our partners and provide the help they need.

Every opportunity is unique, with tailored roles and terms that provide the best path to success.

Industry

Consumer Products Consumer Services (B2C) Healthcare Services Life Sciences HealthTech Biotechnology Business Services (B2B) Chemicals Digital Fashion/Beauty Medical Devices Pharmaceuticals MedTech

Contacts

Name
Title
Email
avatar
Jeanne Bolger, MB BCh Vice President, Venture Investments
Vice President, Venture Investments
-
avatar
Claire Leurent, PhD. MBA Principal, Venture Investments
Principal, Venture Investments
-
Upgrade to see contacts
avatar
6AOHP5MiUjfcsBWk 6AOHP5MiUjfcsBWk
6AOHP5MiUjfcsBWk
avatar
6AOHP5MiUjfcsBWk 6AOHP5MiUjfcsBWk
6AOHP5MiUjfcsBWk
avatar
6AOHP5MiUjfcsBWk 6AOHP5MiUjfcsBWk
6AOHP5MiUjfcsBWk
Investment-team contacts for Johnson & Johnson — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Johnson & Johnson

Johnson & Johnson operates as a corporate VC (CVC). It backs companies at Seed and Series B, writing tickets of $0-1 m.
Johnson & Johnson is located in United States.
Johnson & Johnson was founded in .
Johnson & Johnson invests in companies and startups in Consumer Products, Consumer Services (B2C), Healthcare Services, Life Sciences, HealthTech, Biotechnology, Business Services (B2B), Chemicals, Digital, Fashion/Beauty, Medical Devices, Pharmaceuticals, MedTech.
Johnson & Johnson invests in companies and startups in North America, Europe.
Johnson & Johnson invests in companies and startups at Seed, Series B.
Johnson & Johnson usually invests $0-1 m on average.
Yes, Johnson & Johnson is impact investor.
Johnson & Johnson can be reached through its website jnjinnovation.com/jjdc, its LinkedIn page and its X account. Its general enquiries address is -. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Johnson & Johnson — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Johnson & Johnson directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 27 November, 2021. Something out of date here? Report it — we re-run that firm within 48h and get back to you.